A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...
Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...
Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results